Status:
COMPLETED
Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept
Lead Sponsor:
University Hospital, Lille
Conditions:
SARS-CoV Infection
Covid19
Eligibility:
All Genders
Brief Summary
The main objective of this CorDial-S proof-of-concept study is to evaluate the ability to detect COVID-19 infection in nasopharyngeal swabs with CorDial-S and compare it to the PCR technique currently...
Eligibility Criteria
Inclusion
- Male or female or child without age limit
- Admitted to a Reference Health Establishment (RHS) in an emergency unit, hospitalization or intensive care unit for suspicion of SARS-CoV-2 infection regardless of clinical presentation and degree of severity.
- Patient to be diagnosed by PCR test on nasopharyngeal swab.
- Social insured
Exclusion
- Refusal of the person to participate (collection of information, second use of his sample, collection of saliva by spitting)
- Pregnant and breastfeeding women
- Protected Majors
Key Trial Info
Start Date :
July 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 2 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04780334
Start Date
July 7 2021
End Date
May 2 2022
Last Update
December 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Roger Salengro, CHU Lille
Lille, France, 59037